
Professor Peter Vickerman
BSc(Edin.), DPhil(Oxon.)
Current positions
Professor of Infectious Disease Modelling
Epidemiology and Health Data Science
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Projects and supervisions
Research projects
DIALS – DIAgnosis of Liver diseaSe in primary care
Principal Investigator
Role
Principal Investigator
Description
Plain English Summary of Research:
Background to the study:
Liver disease is a major problem, especially in people under 65 years. It often develops without showing any symptoms, over many years. People…Managing organisational unit
Bristol Medical School (PHS)Dates
02/11/2026 to 01/12/2031
Emergency department opt-out HIV, hepatitis B and hepatitis C testing
Principal Investigator
Role
Co-Investigator
Description
While there was some variation in staff knowledge and understanding of the programme, overall acceptance of the opt-out testing approach was found to be high. Training had a positive impact…Managing organisational unit
Bristol Medical School (PHS)Dates
01/04/2022 to 31/03/2027
Context-specific factors that drive HIV transmission among men who have sex with men: Modelling the role of behavioural, social and legal factors
Principal Investigator
Role
Principal Investigator
Description
Men who have sex with men (MSM) are at high risk of HIV infection.
Behavioural, legal and social factors all contribute to this heightened
risk. Epidemiological analysis and modelling will be used…Managing organisational unit
Bristol Medical SchoolDates
04/10/2021 to 01/04/2024
Mechanistic hydro-epidemiological modelling to reduce human and animal fasciolosis risk in Bolivia through improved environmental management
Principal Investigator
Description
Climate change, poor sanitation and increasing closeness of animals and humans are factors that have led to a rise in infectious diseases across the developing world. Fasciolosis is a Neglected…Dates
01/01/2019 to 31/05/2019
Building the evidence base for cost-effective treatment scale-up for hepatitis C virus in Pakistan healthcare settings
Principal Investigator
Role
Collaborator
Description
Pakistan’s expanding hepatitis C virus (HCV) epidemic makes up >10% of the global disease burden. Increasing accessibility to highly-effective curative HCV treatment presents an opportunity for healthcare providers in Pakistan…Managing organisational unit
Bristol Medical School (PHS)Dates
15/11/2018 to 31/07/2019
Thesis supervisions
Investigating the epidemiology of hepatitis C virus (HCV) infection in different settings around the world
Supervisors
Eliminating hepatitis C in the UK among men who have sex with men during the era of pre-exposure prophylaxis
Supervisors
Investigating hepatitis C transmission dynamics and disease implications in Sindh province, Pakistan
Supervisors
Informing the treatment and prevention response for HIV among people who inject drugs
Supervisors
Publications
Recent publications
01/01/2026Addressing policy barriers to scaling up needle and syringe programmes: a global call to action
Lancet Global Health
A non-randomised trial of a hepatitis C same-day test and treat model using antibody test only for people who inject drugs in Armenia, Georgia, and Tanzania: a CUTTS HepC study protocol
BMJ Open
Can real-world scaling up HCV treatment in people who inject drugs be cost-saving: an economic modelling study in the UK
International Journal of Drug Policy
Characteristics of People Who Inject Drugs Approached for Injection Assistance in Rural Kentucky
Journal of Studies on Alcohol and Drugs
Corrigendum to "Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation" [International Journal of Drug Policy, Volume 150, April 2026, 105174]
The International journal on drug policy


